Dharmacon, Akceli Sign Research Agreement to Combine Technologies

Nov 03, 2003

NEW YORK, Nov. 3 (GenomeWeb News) - Dharmacon has signed on to a research collaboration with Akceli, of Cambridge, Mass. to study ways to combine Dharmacon's short interfering RNA with Akceli's reverse-transfection technology, the companies said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Hundreds of Thousands Wasted

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Down in the Comments

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

Mistrust Lingers

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

This Week in PLOS

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.

Main menu